Renal clearance of oxipurinol, the chief metabolite of allopurinol
Authors:
- Gertrude B. ElionGEGertrude B. Elion
- Ts'AI-Fan YüTYTs'AI-Fan Yü
- Alexander B. GutmanAGAlexander B. Gutman
- George H. HitchingsGHGeorge H. Hitchings
- 1 July 1968
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 45 (1) , 69-77
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Session I: Biochemistry and Metabolism: Effects of Alloplurnol in Relation to Purine BiosynthesisAnnals of the Rheumatic Diseases, 1966
- Metabolic Effects of Allopurinol and Allo-XanthineAnnals of the Rheumatic Diseases, 1966
- Enzymatic and Metabolic Studies with AllopurinolAnnals of the Rheumatic Diseases, 1966
- Metabolic studies of allopurinol, an inhibitor of xanthine oxidaseBiochemical Pharmacology, 1966
- Use of Allopurinol for Prevention and Control of Hyperuricemia in Patients with Neoplastic DiseaseNew England Journal of Medicine, 1966
- Allopurinol in the Treatment of GoutAnnals of Internal Medicine, 1966
- Prevention of Hyperuricemia in Leukemia and LymphomaJAMA, 1965
- Effect of allopurinol (4-Hydroxypyrazolo-(3,4-d)pyrimidine) on serum and urinary uric acid in primary and secondary goutThe American Journal of Medicine, 1964
- Tubular secretion of urate in the dogAmerican Journal of Physiology-Legacy Content, 1960
- ON THE COLORIMETRIC DETERMINATION OF CREATININE BY THE JAFFE REACTIONJournal of Biological Chemistry, 1945